Performance analysis of GT Biopharma (GTBP)
Annual Return
Over the past 3 years, GTBP has had an average annual return of -66.70%, underperforming the benchmark SPY, which returned +22.45% annual.
Over the past 5 years, GTBP has had an average annual return of -77.12%, underperforming the benchmark SPY, which returned +13.88% annual.
Since Sep 22, 2017, GTBP has had an average annual return of -65.30%, underperforming the benchmark SPY, which returned +15.31% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -50.00% | -80.00% | -58.33% | -71.43% | -70.93% | -57.75% | +422.14% | -87.50% | -85.40% | -28.23% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0% | +0% | -50.00% | +0% | +100% | -50.00% | -50.00% | ||||||
| 2025 | -30.00% | +14.29% | -12.50% | +14.29% | +0% | +37.50% | -45.45% | -50.00% | -33.33% | +0% | +0% | +0% | -80.00% |
| 2024 | -20.83% | -31.58% | +7.69% | -35.71% | +33.33% | -25.00% | -11.11% | -12.50% | +0% | +28.57% | +0% | +11.11% | -58.33% |
| 2023 | -10.71% | -13.33% | -20.00% | -30.77% | -41.67% | +42.86% | -13.33% | -3.85% | -8.00% | +4.35% | -12.50% | +14.29% | -71.43% |
| 2022 | +2.77% | +1.68% | -9.60% | -26.74% | +31% | +8.40% | -2.11% | -11.87% | -31.84% | +5.39% | -10.80% | -46.50% | -70.93% |
| 2021 | +10.82% | -34.83% | +31.38% | +93.68% | +30.15% | -10.09% | -35.83% | -10.70% | -24.20% | -4.07% | -37.03% | -25.13% | -57.75% |
| 2020 | +20.61% | -3.16% | +61.44% | -8.50% | +44.25% | -30.67% | +42.92% | -8.36% | -4.73% | +8.51% | -10.46% | +149.64% | +422.14% |
| 2019 | +5.92% | -27.39% | -32.01% | +13.32% | -25.93% | -17.61% | -6.07% | -20.79% | -21.63% | +23.98% | -23.36% | -37.62% | -87.50% |
| 2018 | -37.52% | -31.65% | +0.52% | -17.82% | -4.46% | +11.37% | +20.94% | +17.34% | -11.48% | -28.52% | -33.32% | -35.03% | -85.40% |
| 2017 | -18.39% | +16.60% | -10.51% | -15.72% | -28.23% |
Drawdown analysis of GT Biopharma (GTBP)
The maximum drawdown for the GTBP was -99.99%, occurring on Feb 11, 2026. This drawdown has not yet recovered.
The current GTBP drawdown is -99.99%.
Since Sep 22, 2017 GTBP has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 2 times
- 20% or more: 2 times
- 10% or more: 2 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.99% | Oct 20, 2017 | 2087 | Feb 11, 2026 | Ongoing | Ongoing | Ongoing |
| -31.45% | Sep 22, 2017 | 13 | Oct 11, 2017 | 4 | Oct 17, 2017 | 17 |